INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138447, 3424, 0.3, 0.6, 'mg', 'SL', NULL, 'Adult', X'789c33d03356d05530d033cb4d5708f6512834cdcdccd351c84dacb052305648c92f4e2d5628cf2cc9c8cc5330345500ca01003cc60e2a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138448, 3424, 5.0, 5.0, 'mcg', 'IV', NULL, 'Adult', X'789cf30c5348cb2fcab5523055c84d4ed7cfcdcc53f00cd351c8cc4b2e4a4d2c4e5530d5353280cb141aeb9a02693d00bc591068', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138449, 3424, 5.0, 200.0, 'mcg', 'IV', NULL, 'Adult', X'789c33d535323050c84d4ed7cfcdcc53f00cd351282e492c2a513045125348cc4b51c8cc4b2e4a4d2c4e45922934d63505d200b3ca151c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138450, 3424, 1.0, 5.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d43555c84d4ed7cf4ed7cfcdcc53f00cd351282e492c2a5130d03332d535d04396d551c84dacb0523032401203005e641321', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138451, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138452, 326, 750.0, 750.0, 'g', 'PO', NULL, 'Adult', X'789c3337355048cf5508f0d7f70c53283432c950a85030d73534514849ac2c06006edd07cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138453, 326, 500.0, 500.0, 'MG', 'PO', NULL, 'Adult', X'789c33353050f0755708f0d7f70c53283432c950a85030b2504849ac2c06005ae90729', X'789ced5a6d6fdb3812fe2b443ea5a8e3b72669ceb82fae93a6419bac2f4e832ed68541536399178a5449c9b5bac87fbf2165d996ad448ef6a50b9c51b48de4998733c3678633747e3ff074ec8f240de0a0430e3ec14c4d849a53c6e5418d1cc45ad8d7d3280a4da7d1f8ce1f20a82beddb9f786353da304d43f04634b24aed66fbf4a8d93a6a35ef9a6f3b27a79df649bddd3c3b7b73e26481455c498392bf1f5c82044d85fb3982b953bf4b42e89037da23befbd44a0fe57b112badbec55c2aa12498a13c5786fa40de2b1d980ee9ff522357f7f8574ea9006f287b2a089424779a7a406ed04d1442bba9857076c4e375531ef15544c702ecd36f5ff14970f9e01e56a66d1a511ea92d8dc7af76a5ae178b68841e70e9e79c2fb0eca02f21465738cd495aff62c9a3845086f8dafafcf6a419f8188ac6d53df9d63e9e923939211e4d305a37ca28a6024e8513237e90977b7bd43a76a207f940586bfb5a9908f721e22667c249b349ae2ff338edb3275112b02108a77a0be849bb0b60060f5c8eb89ca411cac17c96e8612838a3918d069ab7898a5e361701e9ad8b1618f05c403edf5d3db7707b1bedcd6e8b167bfd0c37d3c8feed04d9a2e89e21ff6c8654db9fad6dde6fd05fb5411523bbb943fbd06e85f6a78464735ffe6131f91bccd9bdbf4a13003c4e23cdd98bbba2d1e1f2a41b6527ddab9cfa2941c1686ac811392609506d8812687febf4a88d1e341efc065a8ded2351da35921e9f710f3cf2add5b64e2d297072d43a5d07384376ecaeff62e286c0f0381ef555180bbaf23c73abafc19754b284dce2a7d21fca0ee90de527ca22278d4db156635c2021033a81a1bc05490549e33b94ae071dcaab09894d8cef3d65807043d25dfd665b68dd13a4dd3c3afe57277b7b7c365dbc6f358f5acbf7f31689a620499a416b52ff6e353b84901b15110f265c5ada7c386ff4cf3bf88e98380c0504208bec58606dd891be9db76ae98229532df9f266158bfd2976b5f3f1592cf8075658527f85d846c44b3e8375cf1c60fad2ad520cf60142dc7cb6d8e50e91abf5ab4e3d9b3c2b9f7aceed68990a1b2cbda325c262fce9613a6acaa5672bc916afbb4280f6131229c20435a66127d5a1bc4ea8b19bc929f1359d71ccc74f4afae43f774369eb97d6e8988d3208fc412b914440e858e27c48059eaaf0c2b2b432686be5f208ac54460b155c6985b8307c87491b05472898d37ed6c1e7f12e56aaa3bc6a3698ce401b18dd0265db3b53d87180e62aded84149c36922e8dc6e528d4c71a247506970a5199669a4fc5445f867ce997becd5b1644e26f824b04c6136683d053a9403e03f62ed867d08f17fe3ae021a487814f53027b1ca2eee07ee943638e91b243be92b2e23ab754f0d8bad7f262b7eab35b34459bdb903e92949741c46b86823c2472ead32391c0bca1ec858cdc977aa25d2ba46b86484fa58e44f9baf1bdc1e40cae6a1b512bc06d211c1b1e906adb88715045ee5180c73ca408f17c60f00a30ee443122a5f240c700a1bcadf5a5f0b9aabf45a2317ed1b8af0b431c3e12d3d066aeb31c407867b15f170b118bea0630f856d3c42cc421b0bea5136c5d85f49a30269973fe73f7e60d530260d4c1a89171c61856c2827e8ba708ef4eb1c2987e9d5472be91c4ec6a9728ca5644e7fc5c41deae04a36875140d672b04c69e4c12853caa1aed85e0eb6269bc3d8e05239d0a6420e2d63e10e91ca2473faebc4dd61cfd7a5733879beef40c24c7ee4e4735859ae94a32c2573fa598695eb2f25f3fccbf27297a066a279f6e5d2b984742bd9f480d897fbbfb6dc6f1eaffb7abfaff7fb7abfaff73fabdefffcfa536562dbd37a4feb6769dd9f521c7d9912ca4f72e4fe40c5e448f00974c8e9d11999e2310e483725b8093aa4f76bfff8a439941773a621bd63fbacd1362bc5a654a2105113d265e967ef7088c67ec9352fb68598f2318f0c39bfe9123fd1d40069903b152a8e1102f77c755fe1eeb42b230456d8818c06cbb68b43f9ecfe11f2ce0f86d2c486418878021a590f07e4d05d818904bb9aaba1b467910edcad157e34a39abb4bc675553c06b989a88c50e37628978fe450697727051377218fd80c9de16c813e788d262412b48ff2d8ae7de7d1943010023b31fc872e3dc532f1194597164e10f7f3dd1551122d3994d8d89904dbb100319677ff88ffa5359452118f465872beb4b134a546704930665ad5c8388e9c81580fbc35db50facd33d22bc135cfac4d975ac521e9121369084988b44ba4efba4cfc706919760631d80baf8b3a99504020dbc37e39aeb2e262a5e577c2cfb67058339d8576f72f350db03d49036ad57ed1bea3b4a38645ad67eed4c8bb1ae9d5c8e5811b0996adbe934cd37409fb04d2f2fe1e2a60dc738d39856173ce563782e25ed846de10bf0aca854d04c514638890eddb9f81c3e3a000e6b604e67a30e85658fdfab650ad6cb55ef7e809cdabd2e063cf5f271721ce733ae05ea598e17cf05fc02a5f1caa2fad12f54f75fba5906249a4ecaf19ed6281cb8f1bf0a9cd0fb3097853273e02e2f1afa090d36551418000ecb0893ad54272ad349d63ada484617d434b2ad2f143dd56261183fc51293bb188e1c9ca2b687e143036dcba602ae563ba706305432e06ef3ebdae02b585f4b1df2b022a4b9334b7c7ae1330618d7483b04724f895cbc40654a8aa6cf100b4fdcdba6a61ce94494035033cf4659109a52938a00253b0f2660fa6dcafacdcd72a022cb601d774ccaba54986318b858f3d504508fb4db164184c13d6abe53c3e38825603e8d9b622e514996888b151ae92b9eb301eb75f22c595aafa1a4c357fba9822482b8abd4115627419b6f3d1f3269455f2be81d85b184141c7aec7a01580dec5fa61aa049e92c80fecad29e34530e5991601b68c5a85d385550115113e21f1ab98f52bee2e77d79a8bbec55e2cb122a4b268bfd714b96f1c7da358506dd52b1593773a66cf6441793f003e577f248ffa14c78d583b8420c6f0daa9afcae14b21705b13dba100c7cca4281d4bfdb9e763cd95ad4d924f382b4cc62d906b6ed856464e050d12cf9944abe5d475c25488853a584d2555da8a5bce1e208a0c7fc28cd298583bd2c4c6a691d0d98ead6357527bec6eb77c76cc972a485861fb584e59678ae2f66278a2a9ffc43154d660f435ccf02072bc0381afa5ed68abe5634f289ca8b0fdc4f8e46edf5f3a1bace11cba5f41c9c05e55a912b159db3709cc55325dadf1ef431829373646d9c4f564c27fddbe6bd95f99fc7f5c99bcf00a6e0030ea0aa30ef2df8b2e434f0eaf2997afaade671723957db3b6d4192d741ebf3e3e3efe0f20133566', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138454, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'789ced5a6d6fdb3812fe2b443ea5a8e3b72669ceb82fae93a6419bac2f4e832ed68541536399178a5449c9b5bac87fbf2165d996ad448ef6a50b9c51b48de4998733c3678633747e3ff074ec8f240de0a0430e3ec14c4d849a53c6e5418d1cc45ad8d7d3280a4da7d1f8ce1f20a82beddb9f786353da304d43f04634b24aed66fbf4a8d93a6a35ef9a6f3b27a79df649bddd3c3b7b73e26481455c498392bf1f5c82044d85fb3982b953bf4b42e89037da23befbd44a0fe57b112badbec55c2aa12498a13c5786fa40de2b1d980ee9ff522357f7f8574ea9006f287b2a089424779a7a406ed04d1442bba9857076c4e375531ef15544c702ecd36f5ff14970f9e01e56a66d1a511ea92d8dc7af76a5ae178b68841e70e9e79c2fb0eca02f21465738cd495aff62c9a3845086f8dafafcf6a419f8188ac6d53df9d63e9e923939211e4d305a37ca28a6024e8513237e90977b7bd43a76a207f940586bfb5a9908f721e22667c249b349ae2ff338edb3275112b02108a77a0be849bb0b60060f5c8eb89ca411cac17c96e8612838a3918d069ab7898a5e361701e9ad8b1618f05c403edf5d3db7707b1bedcd6e8b167bfd0c37d3c8feed04d9a2e89e21ff6c8654db9fad6dde6fd05fb5411523bbb943fbd06e85f6a78464735ffe6131f91bccd9bdbf4a13003c4e23cdd98bbba2d1e1f2a41b6527ddab9cfa2941c1686ac811392609506d8812687febf4a88d1e341efc065a8ded2351da35921e9f710f3cf2add5b64e2d297072d43a5d07384376ecaeff62e286c0f0381ef555180bbaf23c73abafc19754b284dce2a7d21fca0ee90de527ca22278d4db156635c2021033a81a1bc05490549e33b94ae071dcaab09894d8cef3d65807043d25dfd665b68dd13a4dd3c3afe57277b7b7c365dbc6f358f5acbf7f31689a620499a416b52ff6e353b84901b15110f265c5ada7c386ff4cf3bf88e98380c0504208bec58606dd891be9db76ae98229532df9f266158bfd2976b5f3f1592cf8075658527f85d846c44b3e8375cf1c60fad2ad520cf60142dc7cb6d8e50e91abf5ab4e3d9b3c2b9f7aceed68990a1b2cbda325c262fce9613a6acaa5672bc916afbb4280f6131229c20435a66127d5a1bc4ea8b19bc929f1359d71ccc74f4afae43f774369eb97d6e8988d3208fc412b914440e858e27c48059eaaf0c2b2b432686be5f208ac54460b155c6985b8307c87491b05472898d37ed6c1e7f12e56aaa3bc6a3698ce401b18dd0265db3b53d87180e62aded84149c36922e8dc6e528d4c71a247506970a5199669a4fc5445f867ce997becd5b1644e26f824b04c6136683d053a9403e03f62ed867d08f17fe3ae021a487814f53027b1ca2eee07ee943638e91b243be92b2e23ab754f0d8bad7f262b7eab35b34459bdb903e92949741c46b86823c2472ead32391c0bca1ec858cdc977aa25d2ba46b86484fa58e44f9baf1bdc1e40cae6a1b512bc06d211c1b1e906adb88715045ee5180c73ca408f17c60f00a30ee443122a5f240c700a1bcadf5a5f0b9aabf45a2317ed1b8af0b431c3e12d3d066aeb31c407867b15f170b118bea0630f856d3c42cc421b0bea5136c5d85f49a30269973fe73f7e60d530260d4c1a89171c61856c2827e8ba708ef4eb1c2987e9d5472be91c4ec6a9728ca5644e7fc5c41deae04a36875140d672b04c69e4c12853caa1aed85e0eb6269bc3d8e05239d0a6420e2d63e10e91ca2473faebc4dd61cfd7a5733879beef40c24c7ee4e4735859ae94a32c2573fa598695eb2f25f3fccbf27297a066a279f6e5d2b984742bd9f480d897fbbfb6dc6f1eaffb7abfaff7fb7abfaff73fabdefffcfa536562dbd37a4feb6769dd9f521c7d9912ca4f72e4fe40c5e448f00974c8e9d11999e2310e483725b8093aa4f76bfff8a439941773a621bd63fbacd1362bc5a654a2105113d265e967ef7088c67ec9352fb68598f2318f0c39bfe9123fd1d40069903b152a8e1102f77c755fe1eeb42b230456d8818c06cbb68b43f9ecfe11f2ce0f86d2c486418878021a590f07e4d05d818904bb9aaba1b467910edcad157e34a39abb4bc675553c06b989a88c50e37628978fe450697727051377218fd80c9de16c813e788d262412b48ff2d8ae7de7d1943010023b31fc872e3dc532f1194597164e10f7f3dd1551122d3994d8d89904dbb100319677ff88ffa5359452118f465872beb4b134a546704930665ad5c8388e9c81580fbc35db50facd33d22bc135cfac4d975ac521e9121369084988b44ba4efba4cfc706919760631d80baf8b3a99504020dbc37e39aeb2e262a5e577c2cfb67058339d8576f72f350db03d49036ad57ed1bea3b4a38645ad67eed4c8bb1ae9d5c8e5811b0996adbe934cd37409fb04d2f2fe1e2a60dc738d39856173ce563782e25ed846de10bf0aca854d04c514638890eddb9f81c3e3a000e6b604e67a30e85658fdfab650ad6cb55ef7e809cdabd2e063cf5f271721ce733ae05ea598e17cf05fc02a5f1caa2fad12f54f75fba5906249a4ecaf19ed6281cb8f1bf0a9cd0fb3097853273e02e2f1afa090d36551418000ecb0893ad54272ad349d63ada484617d434b2ad2f143dd56261183fc51293bb188e1c9ca2b687e143036dcba602ae563ba706305432e06ef3ebdae02b585f4b1df2b022a4b9334b7c7ae1330618d7483b04724f895cbc40654a8aa6cf100b4fdcdba6a61ce94494035033cf4659109a52938a00253b0f2660fa6dcafacdcd72a022cb601d774ccaba54986318b858f3d504508fb4db164184c13d6abe53c3e38825603e8d9b622e514996888b151ae92b9eb301eb75f22c595aafa1a4c357fba9822482b8abd4115627419b6f3d1f3269455f2be81d85b184141c7aec7a01580dec5fa61aa049e92c80fecad29e34530e5991601b68c5a85d385550115113e21f1ab98f52bee2e77d79a8bbec55e2cb122a4b268bfd714b96f1c7da358506dd52b1593773a66cf6441793f003e577f248ffa14c78d583b8420c6f0daa9afcae14b21705b13dba100c7cca4281d4bfdb9e763cd95ad4d924f382b4cc62d906b6ed856464e050d12cf9944abe5d475c25488853a584d2555da8a5bce1e208a0c7fc28cd298583bd2c4c6a691d0d98ead6357527bec6eb77c76cc972a485861fb584e59678ae2f66278a2a9ffc43154d660f435ccf02072bc0381afa5ed68abe5634f289ca8b0fdc4f8e46edf5f3a1bace11cba5f41c9c05e55a912b159db3709cc55325dadf1ef431829373646d9c4f564c27fddbe6bd95f99fc7f5c99bcf00a6e0030ea0aa30ef2df8b2e434f0eaf2997afaade671723957db3b6d4192d741ebf3e3e3efe0f20133566', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138455, 326, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0d7f70c53283432c950a85030d73534504849ac2c06006a2f07a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138456, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030d73534514849ac2c06006b0607af', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138457, 326, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c333235c84d5708f0d7f70c53283432c950a850304e49ac2c060050b306f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138458, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'789ced5a6d6fdb3812fe2b443ea5a8e3b72669ceb82fae93a6419bac2f4e832ed68541536399178a5449c9b5bac87fbf2165d996ad448ef6a50b9c51b48de4998733c3678633747e3ff074ec8f240de0a0430e3ec14c4d849a53c6e5418d1cc45ad8d7d3280a4da7d1f8ce1f20a82beddb9f786353da304d43f04634b24aed66fbf4a8d93a6a35ef9a6f3b27a79df649bddd3c3b7b73e26481455c498392bf1f5c82044d85fb3982b953bf4b42e89037da23befbd44a0fe57b112badbec55c2aa12498a13c5786fa40de2b1d980ee9ff522357f7f8574ea9006f287b2a089424779a7a406ed04d1442bba9857076c4e375531ef15544c702ecd36f5ff14970f9e01e56a66d1a511ea92d8dc7af76a5ae178b68841e70e9e79c2fb0eca02f21465738cd495aff62c9a3845086f8dafafcf6a419f8188ac6d53df9d63e9e923939211e4d305a37ca28a6024e8513237e90977b7bd43a76a207f940586bfb5a9908f721e22667c249b349ae2ff338edb3275112b02108a77a0be849bb0b60060f5c8eb89ca411cac17c96e8612838a3918d069ab7898a5e361701e9ad8b1618f05c403edf5d3db7707b1bedcd6e8b167bfd0c37d3c8feed04d9a2e89e21ff6c8654db9fad6dde6fd05fb5411523bbb943fbd06e85f6a78464735ffe6131f91bccd9bdbf4a13003c4e23cdd98bbba2d1e1f2a41b6527ddab9cfa2941c1686ac811392609506d8812687febf4a88d1e341efc065a8ded2351da35921e9f710f3cf2add5b64e2d297072d43a5d07384376ecaeff62e286c0f0381ef555180bbaf23c73abafc19754b284dce2a7d21fca0ee90de527ca22278d4db156635c2021033a81a1bc05490549e33b94ae071dcaab09894d8cef3d65807043d25dfd665b68dd13a4dd3c3afe57277b7b7c365dbc6f358f5acbf7f31689a620499a416b52ff6e353b84901b15110f265c5ada7c386ff4cf3bf88e98380c0504208bec58606dd891be9db76ae98229532df9f266158bfd2976b5f3f1592cf8075658527f85d846c44b3e8375cf1c60fad2ad520cf60142dc7cb6d8e50e91abf5ab4e3d9b3c2b9f7aceed68990a1b2cbda325c262fce9613a6acaa5672bc916afbb4280f6131229c20435a66127d5a1bc4ea8b19bc929f1359d71ccc74f4afae43f774369eb97d6e8988d3208fc412b914440e858e27c48059eaaf0c2b2b432686be5f208ac54460b155c6985b8307c87491b05472898d37ed6c1e7f12e56aaa3bc6a3698ce401b18dd0265db3b53d87180e62aded84149c36922e8dc6e528d4c71a247506970a5199669a4fc5445f867ce997becd5b1644e26f824b04c6136683d053a9403e03f62ed867d08f17fe3ae021a487814f53027b1ca2eee07ee943638e91b243be92b2e23ab754f0d8bad7f262b7eab35b34459bdb903e92949741c46b86823c2472ead32391c0bca1ec858cdc977aa25d2ba46b86484fa58e44f9baf1bdc1e40cae6a1b512bc06d211c1b1e906adb88715045ee5180c73ca408f17c60f00a30ee443122a5f240c700a1bcadf5a5f0b9aabf45a2317ed1b8af0b431c3e12d3d066aeb31c407867b15f170b118bea0630f856d3c42cc421b0bea5136c5d85f49a30269973fe73f7e60d530260d4c1a89171c61856c2827e8ba708ef4eb1c2987e9d5472be91c4ec6a9728ca5644e7fc5c41deae04a36875140d672b04c69e4c12853caa1aed85e0eb6269bc3d8e05239d0a6420e2d63e10e91ca2473faebc4dd61cfd7a5733879beef40c24c7ee4e4735859ae94a32c2573fa598695eb2f25f3fccbf27297a066a279f6e5d2b984742bd9f480d897fbbfb6dc6f1eaffb7abfaff7fb7abfaff73fabdefffcfa536562dbd37a4feb6769dd9f521c7d9912ca4f72e4fe40c5e448f00974c8e9d11999e2310e483725b8093aa4f76bfff8a439941773a621bd63fbacd1362bc5a654a2105113d265e967ef7088c67ec9352fb68598f2318f0c39bfe9123fd1d40069903b152a8e1102f77c755fe1eeb42b230456d8818c06cbb68b43f9ecfe11f2ce0f86d2c486418878021a590f07e4d05d818904bb9aaba1b467910edcad157e34a39abb4bc675553c06b989a88c50e37628978fe450697727051377218fd80c9de16c813e788d262412b48ff2d8ae7de7d1943010023b31fc872e3dc532f1194597164e10f7f3dd1551122d3994d8d89904dbb100319677ff88ffa5359452118f465872beb4b134a546704930665ad5c8388e9c81580fbc35db50facd33d22bc135cfac4d975ac521e9121369084988b44ba4efba4cfc706919760631d80baf8b3a99504020dbc37e39aeb2e262a5e577c2cfb67058339d8576f72f350db03d49036ad57ed1bea3b4a38645ad67eed4c8bb1ae9d5c8e5811b0996adbe934cd37409fb04d2f2fe1e2a60dc738d39856173ce563782e25ed846de10bf0aca854d04c514638890eddb9f81c3e3a000e6b604e67a30e85658fdfab650ad6cb55ef7e809cdabd2e063cf5f271721ce733ae05ea598e17cf05fc02a5f1caa2fad12f54f75fba5906249a4ecaf19ed6281cb8f1bf0a9cd0fb3097853273e02e2f1afa090d36551418000ecb0893ad54272ad349d63ada484617d434b2ad2f143dd56261183fc51293bb188e1c9ca2b687e143036dcba602ae563ba706305432e06ef3ebdae02b585f4b1df2b022a4b9334b7c7ae1330618d7483b04724f895cbc40654a8aa6cf100b4fdcdba6a61ce94494035033cf4659109a52938a00253b0f2660fa6dcafacdcd72a022cb601d774ccaba54986318b858f3d504508fb4db164184c13d6abe53c3e38825603e8d9b622e514996888b151ae92b9eb301eb75f22c595aafa1a4c357fba9822482b8abd4115627419b6f3d1f3269455f2be81d85b184141c7aec7a01580dec5fa61aa049e92c80fecad29e34530e5991601b68c5a85d385550115113e21f1ab98f52bee2e77d79a8bbec55e2cb122a4b268bfd714b96f1c7da358506dd52b1593773a66cf6441793f003e577f248ffa14c78d583b8420c6f0daa9afcae14b21705b13dba100c7cca4281d4bfdb9e763cd95ad4d924f382b4cc62d906b6ed856464e050d12cf9944abe5d475c25488853a584d2555da8a5bce1e208a0c7fc28cd298583bd2c4c6a691d0d98ead6357527bec6eb77c76cc972a485861fb584e59678ae2f66278a2a9ffc43154d660f435ccf02072bc0381afa5ed68abe5634f289ca8b0fdc4f8e46edf5f3a1bace11cba5f41c9c05e55a912b159db3709cc55325dadf1ef431829373646d9c4f564c27fddbe6bd95f99fc7f5c99bcf00a6e0030ea0aa30ef2df8b2e434f0eaf2997afaade671723957db3b6d4192d741ebf3e3e3efe0f20133566', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138459, 326, 16.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d33532c84dd7cf4ed74f49ac54f00c53c82f5208f0d75148c92ccb4c494d51283434ca50a85030345000ca1703004ae50e23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138460, 326, 8.0, 10.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb3d03534c84dd7cf4ed74f49ac54f00c53c82f5208f0d75148c92ccb4c494d51283434ca50a85030345000ca17030042150df3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138461, 7733, 5.0, 7.5, 'mg', NULL, NULL, 'Adult', X'789c0dc2310a80300c05d0abfc5107058722387b915483164c539238f4f6fa783b752c1b1226ac73920b6af4800299cf28c21842c1d55f635076b516452bfe2c2d3a3c54e8b8c70f34b91859', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138462, 7733, 2.5, 7.5, 'mg', NULL, 1, 'Adult', X'789c7349ac54305248cc4b51484aadcccf4bb15230d23355d05530d733cd4d574849cccca954d0282d2e4dcc013280429a006db00f0b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138463, 2177, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf4e57f00cb356c84c53c8cc4b4d4b4b4d2ec92c4bd551484ecc534807b2140ce18a148c0c147233f31412d34a528b14d2328b8a4bc0660100ed0f1cc8', X'789ced5b6d6fdb3812fe2b44800352206e6c274e5af750c0dbb4bb59a4add1647b389c77055aa22d5e2852252527eaa2fffd9ea124dbb293d8cdf5eeb67bfe1258e4cc6838f3cc0b49e5f7bdc8e6d340f344ecf5d9de3016bac88cd47b076c2fb78ac6e22c4b5dfff0f0465e8be4a9b153fa250f1ba42eb43c1551c033e2e8b6bb27ad76a7d5695fb54ffbbde7fdded1d3a3ceb376a7eb69459849a31d287fdffb516861b9f2bf3371ebd9af8a54f4477aa033191a3dcb95e33a73237d661c9f0af6c6d8c4f559c853972be158af7dc03a6dfce9d29fa3769bb14eb777d863c9053b7f7b78fe71a45f9924319a5d591e09f60e6b05ff9954102bf5012b5722ae47fafd24139a8526194b2d227623b398a5d6a485829a6caa8ad0289619267568057782ddf04c58e68ccac752c9ac18e9f3096627b9037b660cfb94cbf05a150750573325388db2a870362eb23891dc1db0b8480d5eeb60930336868a45c86d24f90173427ecead000dd711531c760b190f65649c74de94f978d99a5f3094f1318c82a77ffc8a2725f5b57f585877c5ac9b1dbdcaf0e5577acf20ca5516c025524f1bdebb43afbdcb8c67b90b442a9548212d770d960bc32388615897e8b34eafd56d27d3c3eb293bfff8824932a8984c48de4c94869ce2177c5e13c1f32c919af109796322adcbbcac917ecba5866db90e45259da0924cd9f03d80c13eb193d6b3d8025bd0d066c00d8b4d6e5d25492de9b5d7b42d99e0b2744f1049676c246c634dc061eb985e7518f182457226234002da18d66d1d7991ce4fedbfe5b7aca2c4e01352ba285778dc3af54bdc2082f00df8442b1a372c7937b77f8dc6f3318b69d5298c80c08bfe99571664881a0030857ce141e884cd1300792614ac36987144118c02b90c0b179ade612c93492200e14c805b51a43c603e0ab0b850fc56ba605f8bdc1a97dba9b0c593074002372ea1845e5f2fa9b118b69fac5af7b875b2302a581fb46b8db5f3b7cc9a3c03fc3200641a13636ac54458118d342005650856a0fbc4caf7dfb20ebb1194553abdf65f00b8d2a0e3622e8ca00d21336972a70a3235192de41437abf67a20b44b63fe39226c2d71ec426c17627f9410db61f1abb0785f2cefc0f80dc038f4f6b6327c7c0b16741fb4f737ad11304eaf8e8eba14244b9583cac263dbae95750c94aa90c1ad78c0db2f185737bc70cc796d78c67a0b9c10f633995982f49853330f6f95cbbf232efe7ac212039bf55acf16227cfd1be993c400a085c58e833d6b55d65a2640d497b3a74f7bade76bd3a7e0a9d84fef108fb0e89c54f327cbf9a39a7f59ceb29c029a5a7632008c3bd26fee8adba78cbdaee3ba1a627c1ef513b06007e6d8cb53b297c3468ac4d1d0d37fbf61f96ef0b8a949d901f2bb04e4ce8b7f502f6e7fca513a3215a1e42a189a34577c11a6b52787564c29ca0bf601b3a4739f9d8df4050f334fdd6717f25aa0403b3e112f989289ccbcaba167e229b09c5fb08290e7fe69a43f206d28765699c01f8dc070ef0c7a238cd7f903ef9589d0233d2fde2511f70d1866d08cfd24524ea73c8f927526aa632942e301e389c975c6b48177c4844eb41e7b66b46ab2cd87466774aa5812bb40ea602ea13a3e420b8b3090baee7fdc6ab0093b2de8ac2c54dc21b0200e795aeadc954764879703365626bc3eeceaa875642336f8580e90cd78e25a9799b906a65ca1236b1241ddab9111e3639ba7993fda8b2cbf51d4f47937f6f18bba434716842316a7726055a1898d22b863e662d0fa81ea4797a5f012d59f1a013249b9b44d4f2e8f0d8d45eb6b251fe933c9c722838289504aa2148ef415a648c5b90e6702eda22b5578ad909354f1580faebd6e0b17562cc19ca53ef99b09eb44f041f070dd7597028aa7f5d9303c782b437f304a516ec0795f15bdaa28035724696612178c8b602e28f049f1b7c6ab7e1b5a43691829991a6c74e9d31c8fc8a90a69580bb8980e67c989e42404029e28394c64d8ac0e30d405c927a92f3b6d9abc2cd284b4a0a15f5cce15128236ac566e0f965862f2bb9355b6f761c8c97900462255a40b94846992aff276dbada335de77f7101fd13673957890613345e7c52ab7d8a0d02245181fbce3c02b3f9c1924300adaa6a4e376abb726e942643147e4a1a132748a4d3b9326dbcb75a65726e107d559f5be45797c02a45435d5d266a7e1b58fad37723cd2fbe71f9fac44593984200c8d523c451e2b470634a2a3dc8385a223cbedd8b76995108a34b340da558c801f9b10c04985a660bb10f975fd7b30b55ce7ca4f3b89b01b525a9a93be1553aecc1859c71fb66b91d0e86586f56bd7fad9c4da41894556f1b0656863119e093cad91838d2abc644a82cc7217b37d7f952028a963f32b95e4d0fb4a3a978b9203f4d56a86b94d155d36205896de539942f37aef8c55018b316c8f5f794a09e4bdcb049e150f49e752b3482869659e600de7542d907c2c9a5a20c201cf546647fa6f553284faf5954379f751254b981c0e0086f23bf7aa3e9dd3054bc3cf2be8438a8421467a0e6c2cc6c3168a35604ba9f1f367542be7fc494789427213d442443b62f9a16299c972f2d224da28014c94a723994cbdaa231d0b1ef130c6f8393c97781fff087de40cab8d8b54c0dadccbbcb22231b6322b8f043cc5b3d81fb770e43b36815985f398457152455842a369f461acc4d81bb7f2a6404ed7522c92fa159085de21e67abab6bbdd2a95af27d7afb8ac0be63c3eac1b41b9594c49d6e05c8ae0cdfccbc44d298d10de425093be216b35fc374b5be368c85b248fcd9296681b325692ce16976e2b0c0d69cb196b0bdf2f5337e4dc97d536cb5ce10ce69c4d4fdc9b1bb7f009f10673de6089b7698bbbd2e51646f16c8167bb47fba55cbbcd25e982b8899e2a496f819d9ab2c94fa97d0b664fd6e05c2dff1b65dcd92fd4d2287b6f16e1a99a5acc1b99cdef6ff63c733ff832b1850b4aba06efbc946cd3eed6a42bb1362f3bdb84da82b82165b9266d16d3a06ec8a9abd93619b2a26cf0d7357033ff9cb2c17f57e5dc2cabe60a96b956abc8a2a66e554796c8bfec7acd3f75afb9ba53dc359bffbd6673d718ee1ac35d63b86b0c778de1ae31fc4e1bc35dbbf0e876e131370dbbecb2cb2eff47d9651873b421d8459a69d1c8313f7135692939117d76da3af6df93d08e0ff1639474499f293913f6057bf5f7e171afdd67dd57cffd3700dd579de723fdfa36b4a2bc8d1e4b557e8c975b00856450804204331336084ba2ea2b02ecb3e8833aba729a1905588b562452ba78d7197b37f0625e0d7c846ba1bef27f08aa6db60806ca99c65ad7fe55a3fa98a2fa94c1bfd68aeaee9a12d1faf5e0bdeddaffe67f1c1addf0038bd9a223aebe2b29b90370070bee66ccff070ef6bf6d17ec11f0c17f068972d63c6b799d9a903e6cf1288f5cc8d3af741f76a45ffe05ac3b2456', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138464, 2177, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb552303430c84d5708f0d7f70c53285430d3b5c8282a0600fad30c14', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138465, 2177, 300.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c333630d0353130c84dd74f49ac5448c92ccb4c494d51c8cc2bc95730d2355648c92f4e2d064b69f8265628405502053501f7bb11bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138466, 2177, 4.0, 7.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dac5448cf2c4b5530d135cf4dd7cf4ed74f018aa4649665a6a4a62864e695e42b18e91a2ba4e417a71683a40085bf101d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138467, 2177, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c73cecf2bce4c492d52c8c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf060a64960115a42864e695e42b18e91a8355142ba46796a5e601f9260a1945c50a890589452500e2a81979', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138468, 2177, 10.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d03532c84dd7cf4e57f00c53c8cc5330064b142b18e99a286414152b24162416952868e42656289818805482a43501ee691561', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138469, 2177, 4.0, 6.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d135cb4dd7cf4ed74f49ac54f00c5348c92ccb4c494d51c8cc2bc95730d2355648c92f4e2d06c902001f0f0dc9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138470, 2177, 100.0, 200.0, 'mg', 'IM', NULL, 'Adult', X'789c333430d0353230c84d57f0f45528543051c8282a56a8503054284f4dcd06006af607e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138471, 2177, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf4e57f00cb356c84c53c8cc4b4d4b4b4d2ec92c4bd551484ecc534807b2140ce18a148c0c147233f31412d34a528b14d2328b8a4bc0660100ed0f1cc8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138472, 2177, 1500.0, 1500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030343530c84dd74f49ac04001e7c044e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138473, 2177, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c25cc4b0a83401004d0abd4054488b8ca2a47a9a44b19d2cec074c7e0edcd67fde0dddc612d146017acecc56428351b2ec3f4a7d1785c417ff30844b2279898b7757cae5f03ab214b76a670677c8256a165d1237f16eaaf0dae5d1e27c85b2809', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138474, 2177, 5.0, 8.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb33153c8cdb75230d5b5c84dd7cf4ed74f49ac5408f0d7f70c03005a080732', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138475, 2177, 8.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33cbcdd73551a82c2ab652b0d03534c84dd7cf4ed74f49ac5408f0d7f70c030088ee08e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138476, 2177, 7.5, 9.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d135af2c2ab65230d733d5b5cc4dd7cf4ed74f49ac5408f0d7f70c0300731b0820', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138477, 2177, 7.0, 8.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d7353450a82c2ab65230d7b5c84dd7cf4ed74f49ac5408f0d7f70c03006f710809', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138478, 2177, 6.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d0353453a82c2ab65230d335cf4dd7cf4ed74f49ac5408f0d7f70c030074af0837', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138479, 2185, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c333330c84dd74f5148c92ccb4c494d51283434d23532c9282a5648cb2f523034504849ac04b30107e40ceb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138480, 2185, 14.0, 14.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334c94dd7cf4ed74f5108f05748c92ccb4c494d51283434d23532c9282a56a83034504849ac2cd651c84dac50c84f53303330006a000a0100faad11a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138481, 1748, 30.0, 30.0, 'mg', 'PO', NULL, 'Adult', X'789c3336c84d5708f0572834d3b5c80000188e038b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138482, 20440, 20.0, 20.0, 'mcg', 'IM', NULL, 'Adult', X'789c73cd4b4f2dcaacd075523032c84d4e57f0f4050039a105b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138483, 20440, 10.0, 10.0, 'mcg', 'IM', NULL, 'Adult', X'789c0b4a4dcecf4dca2c4bac50f070523034c84d4e57f0f4050058ec0729', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138484, 9007, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789cf3cc2b492dcacd2c2949cd2b5148ce492c4dc94c4e2cc9cccfd351282e492cce2c5628cd494e2db252303130c84d5708f05708f1740100219f12b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138485, 9007, 1600.0, 1600.0, 'mg', 'PO', NULL, 'Adult', X'789c0b4b2c4e2ecd492c5248c92cce2f4a492d52c84f53c8cccb033252138bac140ccd0c0c72d31502fc150a8042298995404905235d13a0fab2cc94d4148594fce2d462005b4e17a1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138486, 9007, 1200.0, 1200.0, 'mg', 'PO', 1, 'Adult', X'789cf3cbcfd34dcc49cecfc8cfc94c56484b2c29a954c8c92c4b2db25230343230c84d5708f0574849cccca9040042400e74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138487, 3184, 0.4, 0.4, 'mg', 'PO', 1, 'Adult', X'789c33d033c94d5708f057c8cf4b4e554849cccca954c82f52c8cb4ccf28c9a9040090ad0a3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138488, 3184, 0.4, 0.4, 'mg', 'PO', NULL, 'Adult', X'789c33d033c94d5708f05708f4085628cd2bc9cc51282ec9cf4b5548ad2828cd29cecccf0300b9640bce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138489, 2066, 5.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c1dca4b0a80300c05c0abbca582ad11298237f002ee03c612b4f5d32a787bc559cf30f670a6a1e05190a5ce19b28d43f0f5e2cb0a811f78bd051ca151b3f28a3f0f2378ce72a225048d5796049dbfc3931c1767c12969df62921760cc1ee6', X'789ced58fd6fdb3610fd570e060aa4803f64c7d952a31860a4eb12a0698d344b31cc854053b44c442235924aa216f9dff74839ae958fda758761c0fa936dfaee48bef7eec8e3e75662ca34562c17ad11b52e846105cb65d66a53ab34991f5b3857d851af772d2f45ded526f5df64af616a397e882466ce7b0ca2c14f9da8dfe947e7d1e1283a1845c3ee8bfe70f0220ab6823ba99585e5e7d638c9a592d619e6c7c290133721ca795588d1541db18ccb3227be604a898c6699e697c24cd52b6d592ae8b536b985dd992e9db0a4e7d48c39a2938b364dde2192ce73ade8dcb044d05becd88ec27acad9fa926e31e4d82c13fed79f1ff12b93ea32fcf8b2b62716b519b5a563bc748cef1c6f3ffa79c74999b9181b932a6d60317646b28ce672666496857d4d559b0a66f44d6573964dd5fb8bf3a93ab918d10170cf53da8bbad1cf079da8db3fa03ced5da6cfdb94b38a52792588290244cec70cc62717c4e64e18da8f08e00524e51c3680eaaf92394146d8020889a99abc1bd16018758687884b0993590543daef0c29915732110925da0a3b55639522429b1660d238a16ca0e330eaf4077ed2c93bda2727c103e17f44aa76a5e311783653513bc50d27ccf6252a10dd1cc51bd5e44d44221962f24709c43453d59baa79563ae7e5db5e5146e0083c0d68ef65bfd2cf499be5c83eedfd1246027f5d3a138560eedb981a420db57f0f0007a29a34ed8c3976b405c8deaa81ea1280cdaeaf9786dfc3c9fb42704ff24417654db16dd0323122554cf18acef0af4aa7d0e711404cb5a9e8a84d57a1c815a872c48db6808bdc425091312e9463c8a384389289b3d222ab12d8e3732e1cd428e673606ac9967c41ccd24230e3ea4a1152422f33a21da2cc50952ace0c3434556f187761b564a4bdf48bc2422d66f4fccd8c60d681fcec92aea55b8070bf3564b55473061b4fabaf832ffbcfe87a2131bbb4c4b175906e40bb6573ac112af35ba97dbaa89f4261d14990ae074111e3bccc3d6c22ec0fe3b0e67e760459ee0e3545a3902018cf302d4a418064391965fa5a18efe8d784498e4581a5f2d53483a873103df38b5528e3f5fc625745de2773b3505ef9b3af36b6b154f12a4253744d3a36875dd9c7de3ee6b5a024165fabf2482b1c4e5225923fa2c97196099356e4343065d6f6fc098d628a4cea2d930772b21ac2762022480054090c41b4b3aac09f84f8dcb5497453a0fe61f221d49b37fa5a757e634aabb4f3465c4925c8562a313a17fe9c85f6742a14e8b10b8834b8ace9d41f38bfbea697fbd1b3a91a806590be6f5045446a04028c2f6a71073f2bf92581e3d2aea6d89556ac7e33e4dea8c9d9d37bdd82c007cef1cab931cb03d0b6b901ac5ce2daa511710df0cdb18ed78c1b51eeb8d8a2405fd47790a6ff13f46d28bb708a83d31a5acb7b4d288cf19960fca1e01f1146eb3dca862eef25c64a60a72738dcca0ca58741f22211396b35a554a799bfef35421cafcbf957ef3755bf9f219a36e168ee64d812b69c174ee7b8c1bc929f3e817d6beb64102c617ce19305eb74b258dd34d667deeef4fc4e824e4f367bc2a6e1f308625f0fb072886b8746b4e37f44a8007fb3b737ba7f876832b5d56d22b8c42b9746c415d15b1c1a2bd366e22ec5b105187796cd52724f521baac8baf5f2aeb34bcadccfbb1f39f32367fe4739f32fca7d97abcf0fbdfcc7f4325930b4295c673aad9aaa61d91c7b9f0bdf710f225ae8d24011a7e804673a93361fd1b2f7e9a00e0f0f2208e48fc9fe78d8267cf6c783f039383a5c7ebe087d54f8da3f840e6fd077d5af59759f5618993323b3aa4b6f355a3e34b9d5272fa79d9b27ac698beae6ad6a284e857fc3c2ce623d8fc7fcc1f3dd895ac89944fffba6e3aa42d09e4533f81c9d64e3e50c0d64a8d4757309cdddf866f0ce482a344179a5ebbe183db8c832eb5bd5a444bf03655a27725cbdaf98e568548d7ffb90d6a183136d3fa871d3f6fd6b786092c502dd7c46e8c24568c6be09a9e5112be271667563a34fbc05eefcb0f2b5783b3d2e86b6f3f6f66f4810719b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138490, 2066, 240.0, 48.0, 'mg', 'PO', 1, 'Adult', X'789c0bf0b752303231d035b150c84d574849cccca954c8cc5330d6355148c92ccb4c494d5148c92f4e2d0600e1ad0c32', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138491, 2066, 80.0, 120.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc4bcfcc4bd451c8a82c482d2a49cd2bcecccfb352b030d0353432c84d5708f057305628c9cc4d2d5600ca2ba4245602009d521032', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138492, 2066, 4.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0bf0b75230d1353450c84dd7cf4ed74f49ac54c8cc53305648c92ccb4c494d5148c92f4e2d0600c7cd0b9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138493, 1185, 500.0, 500.0, 'mg', 'IN', NULL, 'Adult', X'789c35cbbb0ac2401046e157f94b052fbbc1905abb144141b0118b8d3b9a816487ec8e31bebd17627dbeb373352596c409b332e02a5dcdc1294bc093b5c1566570fd4302cd71aeb8f5eb4a3c45a784dc98ee8ec31ea3c5877bf7825d401b0ac8f229f5d9a6c1582cadf9f6b4c291068affb73cfd40c44d220aa86072973701c83030', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138494, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c734a4c2e492dca4ccc51f0cc4b4b4d2ec9cccf2b5688363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b630148441670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138495, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789cd32fc9cf2bceccc9c92cc92c5688363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b63151c734aac14e0da2072c660390001a31b62', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138496, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c8b363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b63151c734aac14e0da2072c660390058be1655', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);